Editorial: fenofibrate as second-line therapy in high risk PBC--more answers or more questions? Authors' reply

Aliment Pharmacol Ther. 2016 Mar;43(5):649-50. doi: 10.1111/apt.13519.

A C Cheung¹, M Kowgier^{2

3}, J J Feld^{2

4}

¹ Toronto Centre for Liver Disease, Toronto Western and General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada. angelac.cheung@uhn.ca.
² Toronto Centre for Liver Disease, Toronto Western and General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.
³ Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
⁴ McLaughlin-Rotman Centre for Global Health, University of Toronto, Toronto, ON, Canada.

No abstract available

Publication types